Author

Satoshi Motoya 1

1 Hokkaido Prefectural Welfare Federation of Agricultural Cooperative Sapporo-Sapporo Kosei Hospital,Sapporo,Japan

A PHASE 3 STUDY OF VEDOLIZUMAB IN JAPANESE PATIENTS WITH ULCERATIVE COLITIS: EFFECTS ON TIME TO DISEASE WORSENING AND TREATMENT FAILURE

Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi

Assessment of patients' preference for a new auto-injection pen compared with the prefilled syringe for self-administration of adalimumab in patients with Crohn's disease: a prospective cohort study

Maki Miyakawa, Hiroki Tanaka, Masanori Nojima, Hiroe Hojo, Kayoko Masuya, Megumi Morino, Maiko Wataya, Izumi Akita, Kenta Nakamura, Kohei Sugiyama, Masanao Nasuno, Satoshi Motoya

Assessment of the need for the first intestinal resection in patients with Crohn's disease following Diagnosis: A single-centre cohort study in Japan

Masaki Yamashita, Hiroki Tanaka, Kenta Nakamura, Kohei Sugiyama, Masaki Kato, Maki Miyakawa, Ryosuke Sakemi, Masanao Nasuno, Manabu Ishii, Satoshi Motoya, Fumio Itoh

High platelet count predicts a rapid response to adalimumab and a favourable short-term outcome in patients with ulcerative colitis: a multi-centre retrospective cohort study

Ryosuke Sakemi, Maki Miyakawa, Hiroki Tanaka, Masanori Nojima, Masanao Nasuno, Satoshi Motoya, Tokuma Tanuma, Manabu Ishii, Hideyuki Yanagisawa, Masaki Yamashita, Nariaki Toita, Ryo Suzuki, Suketo So

LONG-TERM OUTCOME OF INFLIXIMAB MAINTENANCE TREATMENT FOR JAPANESE PATIENTS WITH CROHN’S DISEASE

Hiroki Tanaka, Maki Miyakawa, Masanao Nasuno, Satoshi Motoya

Long-term outcomes of infliximab therapy for patients with Crohn's disease at different times of initiation of infliximab administration: A single-centre cohort study in Japan

Masaki Kato, Hiroki Tanaka, Kenta Nakamura, Kohei Sugiyama, Maki Miyakawa, Ryosuke Sakemi, Masaki Yamashita, Masanao Nasuno, Manabu Ishii, Satoshi Motoya, Fumio Itoh

Long-term outcomes of treatment decision based on the severity of small bowel capsule endoscopy findings in patients with Crohn's disease: A single-centre cohort study in Japan

Masanao Nasuno, Hiroki Tanaka, Kenta Nakamura, Kohei Sugiyama, Maki Miyakawa, Satoshi Motoya

SAFETY AND EFFICACY OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN 363 PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO HAVE SPECIAL SITUATIONS: AN INTERIM ANALYSIS OF A POST-MARKETING SURVEILLANCE STUDY

Satoshi Motoya

SAFETY AND EFFICACY OF GRANULOCYTE AND MONOCYTE ADSORPTIVE APHERESIS IN 363 PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO HAVE SPECIAL SITUATIONS: AN INTERIM ANALYSIS OF A POST-MARKETING SURVEILLANCE STUDY

Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, Taro Osada, Hitoshi Hongo, Tsuguhiro Kimura, Daisuke Saito, Akihito Sakuraba, Chiemi Mizuno, Ayumi Ito, Toshihisa Kobayashi, Daiki Abukawa, Seiichiro Kokuma, Eiji Hosoi

TOFACITINIB 15 MILLIGRAMS TWICE DAILY FOR PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM 8-WEEK INDUCTION STUDIES OCTAVE INDUCTION 1 & 2

David T. Rubin, Satoshi Motoya, Stefan Schreiber, Daniel Quirk, Chudy I. Nduaka, Nervin Lawendy, Deborah A. Woodworth, Wenjin Wang, Chinyu Su, Peter D. R. Higgins

Item 1 - 10 / 10
1